Evidence map›Paper›PMID 40849537›Full record

ArticleCommunications medicine2025

Forecasting the diabetic retinopathy progression using generative adversarial networks.

Huiyu Qiao, Feilong Tang, Huanfen Zhou, Yun Cai, Kairou Guo, Jin Wang, Tong Ma, Lie Ju, Wei Feng, Zhiqiang Ma and 5 more

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Huiyu Qiao *School of Biomedical Engineering, Capital Medical University, Beijing, China.
Feilong Tang *Beijing Airdoc Technology Co., Ltd, Beijing, China.
Huanfen ZhouSenior Department of Ophthalmology, The Third Medical Center of Chinese PLA General Hospital, Beijing, China.
Yun CaiCenter of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center of Chinese PLA General Hospital, Beijing, China.
Kairou GuoDepartment of Biomedical Engineering, Medical Supplies Center of Chinese PLA General Hospital, Beijing, China.
Jin WangCenter of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center of Chinese PLA General Hospital, Beijing, China.
Tong MaBeijing Airdoc Technology Co., Ltd, Beijing, China.
Lie JuBeijing Airdoc Technology Co., Ltd, Beijing, China.
Wei FengBeijing Airdoc Technology Co., Ltd, Beijing, China.
Zhiqiang MaiKang Guobin Healthcare Group Co., Ltd, Beijing, China.
Juan CheniKang Guobin Healthcare Group Co., Ltd, Beijing, China.
Yuan LuoiKang Guobin Healthcare Group Co., Ltd, Beijing, China.
Bin WangBeijing Airdoc Technology Co., Ltd, Beijing, China.
Zongyuan GeBeijing Airdoc Technology Co., Ltd, Beijing, China. zongyuan.ge@monash.edu.ORCID http://orcid.org/0000-0002-5880-8673
Qiansu YangCenter of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center of Chinese PLA General Hospital, Beijing, China. yqs456@126.com.ORCID http://orcid.org/0009-0000-4120-1763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic retinopathy (DR) is the leading cause of blindness worldwide, making early prediction of DR progression crucial for effectively preventing visual loss. This study introduces a prediction framework DRForecastGAN (Diabetic Retinopathy Forecast Generative Adversarial Network), and investigates its clinical value in predicting DR development.

methodsDRForecastGAN model, consisting of a generator, discriminator, and registration network, was trained, validated, and tested in training (12,852 images), internal validation (2734 images), and external test (8523 images) datasets. A pre-trained ResNet50 classification model identified the DR severity on synthetic images. The performance of the proposed DRForecastGAN model was compared with the CycleGAN and Pix2Pix models in image reality and DR severity of the synthesized fundus images by calculating Fréchet Inception Distance (FID), Peak Signal-to-Noise Ratio (PSNR), Structural Similarity Index (SSIM), and area under the curve (AUC).

resultsDRForecastGAN model has the lowest FID, highest PSNR and highest SSIM on internal validation (FID: 27.3 vs. 32.8 vs. 34.4; PSNR: 25.3 vs. 17.0 vs. 16.9; SSIM: 0.93 vs. 0.79 vs. 0.65) and external test (FID: 37.6 vs.45.1 vs.48.4; PSNR: 20.7 vs.15.2 vs.14.7; SSIM: 0.86 vs.0.69 vs.0.63) datasets compared with Pix2Pix and CycleGAN models. In the prediction of DR severity, our DRForecastGAN model outperforms both Pix2Pix and CycleGAN models, achieving the highest AUC values on both internal validation (0.87 vs. 0.76 vs. 0.75) and external test (0.85 vs. 0.70 vs. 0.69) datasets.

conclusionsThe proposed DRForecastGAN model can effectively visualize DR development by synthesizing future fundus images, offering potential utility for both treatment and ongoing monitoring of DR.

Identifiers

PMID40849537
PMCPMC12375066

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.